De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy

De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy

BackgroundIn the era of anti-HER2 targeted therapy, the potential clinical feasibility of considering HER2-overexpressing breast cancer cases presenting with 1-3 positive axillary lymph nodes as low-risk, and thereby contemplating postoperative radiotherapy reduction, remains an important subject fo...

Full description

Bibliographic Details
Main Authors: Jing Liu, Suning Huang, Zhuofei Bi, Xiaoxue Zhang, Ziqing He, Xiaowen Lan, Yuting Tan, Xiao Lin, Wenyi Zhou, Xiaobo Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
HER2 overexpression
radiotherapy
anti-Her2 targeted therapy
early breast cancer
1-3 lymph nodes positive
regional lymph node irradiation
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1280900/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1280900/full

Similar Items